Baseline characteristics of study subjects (n = 136). by Herindita Puspitaningtyas (11618232)

Subjects:

Vitamin D concentration changes between baseline and post-chemotherapy in breast cancer patients (n = 136). by Herindita Puspitaningtyas (11618232)

Subjects:

Minimal data set. by Herindita Puspitaningtyas (11618232)

Subjects:

Flowchart of subjects’ inclusion process. by Herindita Puspitaningtyas (11618232)

Subjects:

The solution of recovered compartment of model (1) asymptotically approaches to the endemic equilibrium for the data (54), the solution is decreasing with increasing in value of <i... by Dilber Uzun Ozsahin (18320075)

Comparison of SF-36 scores of participants with residual limb pain with a VAS score ≥5 and participants with a VAS score <5. by Martin C. Berli (9427264)

Estimation the degree of essentialized human qualities (average of the five qualities) for each of the 16 individual robots, presented as a function of the degree of human resembla... by Tatjana A. Nazir (12262825)

ECE decreases coronavirus RNA in a dose dependent manner. by Siyun Lee (17087351)

A genetic variant in human FIRE is associated with a decreased interferon response in myeloid cells. by Anaïs Assouvie (9600529)

DDX3 levels are not decreased in MCMV-infected cells. by Olha Puhach (9500132)

Fig 5 - by Marian Adan (16641634)

Evaluation of virus CD4/CCR5 utilization using Affinofile cells. by Yiying Zhang (198443)

Effects of Nogo-A and its receptor on the repair of sciatic nerve injury in rats by Junjie Jiang (7255706)

Positioning errors of different algorithms on the a multi-modal and multi-scenario dataset for ground robots dataset. by Hongliang Zou (20707270)

Subjects:

Specific parameters of the test sequence in the a multi-modal and multi-scenario dataset for ground robots dataset. by Hongliang Zou (20707270)

Subjects:

Decreased Expression of TGR5 in Vogt-Koyanagi-Harada (VKH) Disease by Jinglu Yang (6391913)

“…</p> <p><i>Results</i>: A decreased expression of TGR5 in M1 macrophages was observed in active VKH patients as compared with normal controls. …”

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Frequency Chart for optimal maxima case (Frequency = 1.714) (a), second optimal maxima case (Frequency = 1.692) (b), optimal minima case (Frequency = 0.946) (c) and second optimal... by Muhammad Hammad Bucha (21736111)

Subjects:

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)